Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision (v3.4.2) was added to the Record History and the previous revision (v3.4.1) removed, reflecting a minor administrative update; this does not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedA new revision entry v3.4.1 was added to the Record History and the v3.4.0 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe updates introduce UI/display changes such as a glossary toggle, color-coded highlights for changes, and a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the record history and the previous v3.3.3 entry was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' to the Record History. Removed the 'HHS Vulnerability Disclosure' footer link and the older revision 'Revision: v3.3.2' from the page.SummaryDifference0.2%

- Check91 days agoChange DetectedRecord History now lists Revision v3.3.2 and removes Revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.